Through its publications, INSS provides rigorous, forward‑looking research and analysis on critical national security issues that support the joint warfighter and inform Department of War decision‑makers.
April 16, 2026
Breaking (Bad) Biotech — Revisiting the Biological and Toxin Weapons Convention
Dr. Giordano explores how advances in biotechnology, like gene editing and AI, allow adversaries to easily create novel, weaponizable biological agents that are difficult to detect and defend against. In an evolving operational environment, the nature of biological warfare has shifted.
Feb. 17, 2026
The Recent Rash of Biotechnology Risks: A Call to Fortify Force Capability
The tools of modern biology such as state-of-the-art gene editing, modular DNA assembly, cell-free systems, benchtop automation, and AI-enabled formulation have distributed bioweapon capability beyond the skillcraft of traditional state laboratories. Although specialized methods and equipment are required for bioagent manufacture, the relative ease of acquiring and using these means is such that more actors can gain access to such agents and can do so without the need for bespoke facilities.
Dec. 22, 2025
Biotechnologies and the Treaty Gap: Why Biological Weapons Governance Is Falling Behind; and Some Thoughts on How to Fix It
The Scottish ballad Auld Lang Syne, written in 1788 by poet Robert Burns is a tune traditionally played to ring out the passing year and herald in the new. The lyrics offer an invitation to celebrate that which was good, and toast to what may come.
Feb. 19, 2025
Drones and Biotechnological Weaponry: Emerging Risks, Strategic Threats, and Viable Readiness
The United States National Drone Association (USNDA) recently announced its sponsorship of the inaugural, international U.S. Military Drone Crucible Drone Championship to provide a venue for exercising U.S. and allied military drone training, advanced piloting, operational utility, and counter-measures’ capability.